David Planchard: revolutionising targeted therapies for lung cancer
… Adaptation to Kinase Inhibitors team withinthe Molecular Predictors and New Targets in Oncology unit (PMNCO - Univ. … therapeutic trials for lung cancer."I realised that this was exactly what I wanted to do."» David Planchard then … of targeted therapies." ». This treatment became the global standard,entering the guidelines of medicines …
Published on: